Rheumatology International

, Volume 32, Issue 4, pp 895–908 | Cite as

The prevalences of some rheumatic diseases in western Turkey: Havsa study

  • Necati Çakır
  • Ömer Nuri Pamuk
  • Emine Derviş
  • Neşe İmeryüz
  • Haşim Uslu
  • Ömer Benian
  • Edip Elelçi
  • Genco Erdem
  • Fatma Oğuz Sarvan
  • Mustafa Şenocak
Original Article

Abstract

To study the prevalence major rheumatic diseases in western Turkey. This survey was conducted in Havsa which have a total population of 18,771. Physicians and interns visited every household, interviewed face to face a questionnaire about the symptoms of rheumatic disorders. The individuals replied positively to any question were examined at the nearest health center. Those have no objective findings related to any rheumatic diseases were excluded. People could not be clinically diagnosed were asked to come to the hospital for further evaluation. A total 17,835 of 18,771 residents participated. We estimated the prevalence of Behçet’s Disease (BD) as 0.019%; ankylosing spondylitis: 0.120%; rheumatoid arthritis: 0.321%; knee osteoarthritis (OA): 5.351%; hand OA: 1.110%; hand and knee OA: 1.958%; total OA: 8.420%; primary Raynaud’s: 1.192%; psoriasis: 0.424 %; psoriatic arthritis: 0.050%; rheumatic fever: 0.318%; rheumatic heart disease: 0.200%; inflammatory bowel disease: 0.023%; lupus: 0.059%; gout: 0.018%; systemic sclerosis: 0.022%; juvenile rheumatoid arthritis: 0.032%; temporal arteritis: 0.020%, and familial Mediterranean fever (FMF) as 0.006%. Figures were adjusted for age-sex of the general Turkish population. The prevalence’s of BD and FMF are considerably lower in Havsa as compared to other regions in Turkey.

Keywords

Behcet’s disease Familial Mediterranean fever Rheumatoid arthritis Ankylosing spondylitis Epidemiology Psoriasis 

Notes

Acknowledgments

We would like to thank Dr Hasan Yazıcı for critical review. We are grateful to all the medical students who participated in the study. This study was supported by the Trakya University Scientific Research Project Fund (Project number: TÜBAP-477).

References

  1. 1.
    Silman AJ, Hochberg MC (2001) Epidemilogy of the rheumatic disases, 2nd edn. Oxford University Press, OxfordGoogle Scholar
  2. 2.
    Demirhindi O, Yazıcı H, Binyıldız P (1981) Silivri Fener Köyü ve Yöresinde Behçet Hastalığı sıklığı ve bu hastalığın toplum içinde taranmasında kullanılabilecek bir yöntem. Cerrahpaşa Tıp–Fak Der 12:509–514Google Scholar
  3. 3.
    Yurdakul S, Günaydın I, Tüzün Y, Tankurt N, Pazarli H, Ozyazgan Y et al (1988) The prevalence of Behçet’s syndrome in a rural area Northern Turkey. J Rheumatol 15:115–117Google Scholar
  4. 4.
    Idil A, Gurler A, Boyvat A, Caliskan D, Ozdemir O, Isik A et al (2002) The prevalence of Behçet’s disease above the age of ten years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol 9:325–331PubMedCrossRefGoogle Scholar
  5. 5.
    Azizlerli G, Kose AK, Sarıca R, Gul A, Tutkun IT, Kulaç M et al (2003) Prevalence of Behçet’s disease in İstanbul, Turkey. Int J Dermatol 42:803–806PubMedCrossRefGoogle Scholar
  6. 6.
    Akar S, Birlik M, Gurler O, Sari I, Onen F, Manisali M et al (2004) The prevalence of rhematoid arthritis in an urban population of İzmir–Turkey. Clin Exp Rheumatol 22:416–420PubMedGoogle Scholar
  7. 7.
    Kacar C, Gilgil E, Tuncer T, Bütün B, Urhan S, Arikan V et al (2005) Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 24:212–214PubMedCrossRefGoogle Scholar
  8. 8.
    Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E et al (1998) Prevalence of chronic arthritis and familial Mediterranean fever in Turkey: a field survey. J Rheumatol 25:2445–2449PubMedGoogle Scholar
  9. 9.
    Cobankara V, Fidan G, Türk T, Zencir M, Colakoglu M, Ozen S et al (2004) The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol 22(suppl, 34):S27–S30PubMedGoogle Scholar
  10. 10.
    Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H et al (2004) Increased frequency of familial Mediterranean fever in Central Anatolia Turkey. Clin Exp Rheumatol 22(Suppl.34):31–33Google Scholar
  11. 11.
    Dinc A, Pay S, Turan M, Simsek I (2000) Prevalence of familial Mediterranean fever in young Turkish men. Clin Exp Rheumatol 18(Supl):292Google Scholar
  12. 12.
    Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O et al (2008) Prevalence of ankylosing spondyloarthritis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 35:305–309PubMedGoogle Scholar
  13. 13.
    Cakir N, Dervis E, Benian O, Pamuk ON, Sonmezates N, Rahimoglu R et al (2004) Prevalence of Behçet’s dieases in rural western Turkey: a preliminary report. Clin Exp Rheumatol 22(Suppl. 34):S53–S55PubMedGoogle Scholar
  14. 14.
    Gustincich S, Manfiolett G, Del Sal G, Carninci PA (1991) Fast method for high quality genomic DNA extraction from whole human blood. Bio Tech 11:298–302Google Scholar
  15. 15.
    Buyse R, Decorte M, Baens Z (1993) Rapid DNA typing of class II antigens using the PCR and reverse dot blot hybridization. Tissue Antigens 41:1–14PubMedCrossRefGoogle Scholar
  16. 16.
    International study Group for Behçet’s Dieseas (1990) Criteria for diagnosis of Behçet’s diease. Lancet 335:1078–1080Google Scholar
  17. 17.
    MacGregor AJ, Bamber S, Silman AJ (1994) A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of analysis from a nationwide twin study. J Rheumatol 21:1420–1426PubMedGoogle Scholar
  18. 18.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revise criteria for the classification of systemic lupus erythematosus (SLE). Aritritis Rheum 25:1271–1277CrossRefGoogle Scholar
  19. 19.
    Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J et al (1977) JRA Criteria Subcommite of the diagnosis and therapeutic Critera Committee of the American Rheumatism Association: current proposed revision of JRA criteria. Arthritis Rheum 20:195–199PubMedGoogle Scholar
  20. 20.
    Kellgren JH, Jeffrey M, Ball J (1963) The epidemiolgy of chronic rheumatism, vol 1. Blackwell, Oxford, pp 32–37Google Scholar
  21. 21.
    Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthrits Rheum 40:1879–1885CrossRefGoogle Scholar
  22. 22.
    Subcommitte for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90Google Scholar
  23. 23.
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al (1986) Development of critreria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049PubMedCrossRefGoogle Scholar
  24. 24.
    Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K et al (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601–1610PubMedCrossRefGoogle Scholar
  25. 25.
    Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P et al (1993) Validity and reliability of three methods used in the diagnosis of Raynaud’s phenomenon. The UK Scleroderma study group. Br J Rheumatol 32:357–361PubMedCrossRefGoogle Scholar
  26. 26.
    Dajani AS (2001) Rheumatic fever. Guidelines for the diagnosis of initial attacts of rheumatic fever (Jones Criteria, updated 1992). Heart disease: a textbook of cardiovascular disease. Eugene Branwald, Douglas P Zipes, Peter Libby, pp 2192–2197Google Scholar
  27. 27.
    Nomenclature and Criteria for Diagnosis of the Heart and Great Vessels. The Criteria Committe of the New York Heart Association. 1979; 8th edn, p 260Google Scholar
  28. 28.
    Baker H (2001) Criteria for borderline psoriasis. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, p 86Google Scholar
  29. 29.
    Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227PubMedCrossRefGoogle Scholar
  30. 30.
    Van der Linden S, Valkenburg HA, Cats A (1994) Evulation of diagnosis criteria for ankylosing spondylitis. A proposal for modification of the New York Criteria. Arthritis Rheum 27:361–368CrossRefGoogle Scholar
  31. 31.
    Tobi H, van den Berg PB, den Berg LT (2005) Small proportions: what to report for confidence intervals? Pharmacoepidemiol Drug Saf 14:239–247PubMedCrossRefGoogle Scholar
  32. 32.
    Cakir N, Yazici H, Chamberlain MA, Barnes CG, Yurdakul S, Atasoy S et al (1991) Response to intradermal injection of monosodium urate crystals in Behçet’s syndrome. Ann Rheum Dis 50:634–636PubMedCrossRefGoogle Scholar
  33. 33.
    Carmona L, Villaverde V, Hernández-García C, Ballina J, Gabriel R, Laffon A, EPISER Study Group (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Reumatology (Oxford) 41:88–95CrossRefGoogle Scholar
  34. 34.
    Guillemin F, Saraux A, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E et al (2005) Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 64:1427–1430PubMedCrossRefGoogle Scholar
  35. 35.
    Drosos AA, Alamanos I, Voulgari PV, Psychos DN, Katsaraki A, Papadopoulos I et al (1997) Epidemiology of adult rheumatoid arthritis in northwest Greece 1987–1995. J Rheuamtol 24:2129–2133Google Scholar
  36. 36.
    Stojanovic R, Vlajinac H, Palic-Obradovic D, Janosević S, Adanja B (1998) Prevalence of rheumatoid arthritis in Belgrade, Yugoslavia. Br J Reumatol 37:729–732CrossRefGoogle Scholar
  37. 37.
    Andrianakos A, Trontzas P, Christoyannis F, Kaskani E, Nikolia Z, Tavaniotou E et al (2006) Prevalence and management of rheumatoid arthritis in the general population of Greece-the ESORDIG study. Rheumatology (Oxford) 45:1549–1554CrossRefGoogle Scholar
  38. 38.
    Hanova P, Pavelka K, Dostal C, Holcatova I, Pikhart H, Hanova P (2006) Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey 2002–2003. Clin Exp Rheumatol 24:499–507PubMedGoogle Scholar
  39. 39.
    Steven MM (1992) Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands. Ann Rheum Dis 51:186–194PubMedCrossRefGoogle Scholar
  40. 40.
    Salaffi F, De Angelis R, Grassi W, Salaffi F, De Angelis R, Grassi W (2005) MArche Pain Prevalence; INvestigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample:results of a regional community-based study.1. The MAPPING study. Clin Exp Rheumatol 23:819–828PubMedGoogle Scholar
  41. 41.
    Solomon L, Robin G, Valkenburg HA (1975) Rheumatoid arthritis in an urban South African Negro population. Ann Rheum Dis 34:128–135PubMedCrossRefGoogle Scholar
  42. 42.
    Meyers OL, Daynes G, Beighton P (1977) Rheumatoid arthritis in a tribal Xhosa population in the Transkei, Southern Africa. Ann Rheum Dis 36:62–65PubMedCrossRefGoogle Scholar
  43. 43.
    Beighton P, Solomon L, Valkenburg HA (1975) Rheumatoid arthritis in a rural South African Negro population. Ann Rheum Dis 34:136–141PubMedCrossRefGoogle Scholar
  44. 44.
    Moolenburgh JD, Valkenburg HA, Fourie PB (1986) A population study on rheumatoid arthritis in Lesotho, southern Africa. Ann Rheum Dis 45:691–695PubMedCrossRefGoogle Scholar
  45. 45.
    Brighton SW, de la Harpe AL, van Staden DJ, Badenhorst JH, Myers OL (1988) The prevalence of rheumatoid arthritis in a rural African population. J Rheumatol 15:405–408PubMedGoogle Scholar
  46. 46.
    Dai SM, Han XH, Zhao DB, Shi YQ, Liu Y, Meng JM (2003) Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China; a COPCORD Study. J Rheumatol 30:2245–2251PubMedGoogle Scholar
  47. 47.
    Wigley RD, Zhang NZ, Zeng QY, Shi CS, Hu DW, Couchman K et al (1994) Rheumatic Diseases In China: ILAR-China Study comparing the prevalance of rheuamtic symptoms in Northern and Southern rural populations. J Rheumatol 21:1484–1490PubMedGoogle Scholar
  48. 48.
    Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH (1994) Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 21:302–306PubMedGoogle Scholar
  49. 49.
    Malaviya AN, Kapaoor SK, Singh RR, Kumar A, Pande I (1993) Prevalence of rheumatoid arthritis in the adult Indian population. Rheumatol Int 13:131–134PubMedCrossRefGoogle Scholar
  50. 50.
    Minh Hoa TT, Darmawan J, Chen SL, Van Hung N, Thi Nhi C, Ngoc An T (2003) Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study. J Rheumatol 30:2252–2256PubMedGoogle Scholar
  51. 51.
    Darmawan J, Muirden KD, Valkenburg HA, Wigley RD (1993) The epidemiology of rheumatoid arthritis in Indonesia. Br J Rheumatol 32:537–540PubMedCrossRefGoogle Scholar
  52. 52.
    Chopra A, Patil J, Billempelly V, Relwani J, Tandle HS (2001) WHO-ILAR COPCORD Study. WHO International League of Associations from Rheumatology Community Oriented Program from Control of Rheumatic Diseases. Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study. J Assoc Physicians India 49:240–246PubMedGoogle Scholar
  53. 53.
    Dans LF, Tankeh-Torres S, Amanta CM, Penserge EG (1997) The prevalence of rheumatic diseases in a Filipino urban population: a WHO-ILAR COPCORD Study: World Health Organization. International Leaque of Associations for Rheumatololgy. Community Oriented Programmme for the Control of the Rheumatic Diseases. J Rheumatol 24:1814–1819PubMedGoogle Scholar
  54. 54.
    Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R et al (2008) Rheumatic diseases in China. Arhritis Res Ther 10(1):R17CrossRefGoogle Scholar
  55. 55.
    Uddin MZ, Das BB, Rahman F, Chowdhury MA, Alam MN, Mahmud TA et al (2005) Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 32:348–353PubMedGoogle Scholar
  56. 56.
    Pountain G (1991) The prevalence of rheumatoid arthritis in the Sultanate of Oman. Br J Rheumatol 30:24–28PubMedCrossRefGoogle Scholar
  57. 57.
    Al-Dalan A, Al Ballaa S, Bahabri S, Biyari T, Al Sukait M, Mousa M et al (1998) The prevalence of rheumatoid arthritis in the Qassim region of Saudi Arabia. Ann Saudi Med 18:396–397Google Scholar
  58. 58.
    Lawrence RC, Helmic CG, Arnett FC, Deyo RA, Felson DT, Giannini EH et al (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778–799PubMedCrossRefGoogle Scholar
  59. 59.
    Gabriel SE, Crowson CS, O’Fallon WM (1999) The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985. Arth Rheum 42:415–420CrossRefGoogle Scholar
  60. 60.
    Boyer GS, Lanier AP, Templein DW, Bulkow L (1990) Spondylopathy and rheumatoid arthritis Alaskan Yupik Eskimos. J Rheumatol 17:489–496PubMedGoogle Scholar
  61. 61.
    Boyer GS, Templin DW, Lanier AP (1991) Diseases in Alaskan Indians of the southest coast. High prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 18:1477–1484PubMedGoogle Scholar
  62. 62.
    Gare BA, Fasth A (1992) Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population study. Pediatrics 90:950–958PubMedGoogle Scholar
  63. 63.
    Danner S, Sordet C, Terzic J, Donato L, Velten M, Fischbach M et al (2006) Epidemiology of juvenile idiopathic arthritis in Alsace, France. J Rheumatol 33:1377–1381PubMedGoogle Scholar
  64. 64.
    Manners PJ, Bower C (2002) Worldwide prevalence of juvenil arthritis—why does it vary so much? J Rheumatol 29:1520–1530PubMedGoogle Scholar
  65. 65.
    Mauldin J, Cameron HD, Jeanotte D, Solomon G, Jarvis JN (2004) Chronic arthritis in children and adolescents in two Indian health service user populations. BMC Musculoskelet Disord 27:5–30Google Scholar
  66. 66.
    Hochberg MC, Linet MS, Sills EM (1983) The prevalence and incidence of juvenil rheumatoid arthritis in an urban Black population. Am J Public Health 73:1202–1203PubMedCrossRefGoogle Scholar
  67. 67.
    van Saase JL, van Romunde LK, Cats A, Vandenbroucke JP, Valkenburg HA (1989) Epidemiology of osteoarthritis: Zoetermer survey. Comparison of radiological osteoarthritis in a Dutch popultion with that in 10 other populations. Ann Rheum Dis 48:271–280PubMedCrossRefGoogle Scholar
  68. 68.
    Andrianakos AA, Kontelis LK, Kramitsos DG, Aslanidis SI, Georgountzos AI, Kaziolas GO et al (2006) Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece.The ESORDIG Study. J Rheumatol 33:2507–2514PubMedGoogle Scholar
  69. 69.
    Sun Y, Stürmer T, Günter KP, Brenner H (1997) Incidence and prevalence of cox-and gonarthrosis in the general population. Z Orthop Ihre Grenzgeb 135:184–192 (abstract)PubMedCrossRefGoogle Scholar
  70. 70.
    Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J et al (2007) Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: The Jhonson County. Osteoarthritis Project. J Rheumatol 34:172–180PubMedGoogle Scholar
  71. 71.
    Kaçar C, Gilgil E, Urhan S, Arikan V, Dündar U, Oksüz MC et al (2005) The prevalence of symptomatic knne and distal interphalangeal joint osteoarthritis in the urban population of Antalya.Turkey. Rheumatol Int 25:201–204PubMedCrossRefGoogle Scholar
  72. 72.
    Saraux A, Guillemin F, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E et al (2005) Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis 64:1431–1435PubMedCrossRefGoogle Scholar
  73. 73.
    Alamanos Y, Papadopoulos NG, Voulgari PV, Karakatsanis A, Siozos C, Drosos AA (2004) Epidemiology of ankylosing spondylitis in northwest Greece, 1983–2002. Rheumatology 43:615–618PubMedCrossRefGoogle Scholar
  74. 74.
    Trontzas P, Andrianakos A, Miyakis S, Pantelidou K, Vafiadou E, Garantziotou V (2005) The ESORDIG study group. Seronegative spondyloarthopathies in Greece: a population-based study of prevalence, clincal pattern, and management. The ESORDIG study group. Clin Rheumatol 24:583–589PubMedCrossRefGoogle Scholar
  75. 75.
    Silman AJ (2001) Ankylosing spondylitis and spondyloarthropathies. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 100–101Google Scholar
  76. 76.
    Ng SC, Liao Z, Yu DT, Chan ES, Zhao L, Gu J (2007) Epidemiology of spondyloarthritis in the People’s Republic of China: review of the the literatutre and commentary. Semin Arthritis Rheum 37:39–47PubMedCrossRefGoogle Scholar
  77. 77.
    Saro Gismera C, Riestra Menéndez S, Milla Crespo A, Sánchez Fernandez R, Lacort Fernandez M, Argüelles Fernandez G et al (2003) Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA), Spain. Ann Med Interna 20:3–9Google Scholar
  78. 78.
    Rubin GP, Hungin AP, Kelly PJ, Ling J (2000) Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 14:1553–1559PubMedCrossRefGoogle Scholar
  79. 79.
    Gearry RB, Richardson A, Frampton CM, Collett JA, Burt MJ, Chapman BA et al (2006) High incidence of Crohn’s disease in Canterbury, New Zeland: results of an epidemiology study. Inflamm Bowel Dis 12:936–943PubMedCrossRefGoogle Scholar
  80. 80.
    Abdul-Baki H, ElHajj I, El-Zahabi LM, Azar C, Aoun E, Zantout H et al (2004) Clinical epidemiology of inflamattory bowel disease in Lebanon. Inflamm Bowel Dis 13:475–480CrossRefGoogle Scholar
  81. 81.
    Pinchbeck BR, Kirdeikis J, Thomson AB (1988) Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol 10:505–515PubMedCrossRefGoogle Scholar
  82. 82.
    Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M et al (2006) The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 101:1559–1568PubMedCrossRefGoogle Scholar
  83. 83.
    Herrinton LJ, Liu L, Lafata JE, Allison JE, Andrade SE, Korner EJ et al (2007) Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 4:451–461CrossRefGoogle Scholar
  84. 84.
    Nevitt GJ, Hutchinson PE (1996) Psoriasis in the community: prevalence, severity and patient’s beliefs and attitudes towards the disease. Br J Dermatol 135:533–537PubMedCrossRefGoogle Scholar
  85. 85.
    Ferrándiz C, Bordas X, García-Patos V, Puig S, Pujol R, Smandía A et al (2001) Prevalence of psoriasis in Spain (Epiderma Project: phase 1). J Eur Acad Dermatol Venerol 15:20–23CrossRefGoogle Scholar
  86. 86.
    Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ (2005) Prevalence and treatment of psoriasis in the United Kingdom. A population-based study. Arch Dermatol 141:1537–1541PubMedCrossRefGoogle Scholar
  87. 87.
    Braathen LR, Botten G, Bjerkedal T (1989) Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venerol Suppl (Stockh) 142:9–12Google Scholar
  88. 88.
    Falk ES, Vandbakk O (1993) Prevalence of Psoriasis in a Norwegian Lapp population. Acta Derm Venerol Suppl (Stockh) 182:6–9Google Scholar
  89. 89.
    Silman AJ (2001) Psoriatic arthropathy. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 85–99Google Scholar
  90. 90.
    Taylor WJ (2002) Epidemiology of psoriatic arthritis. Curr Opin Rheumatol 14:98–103PubMedCrossRefGoogle Scholar
  91. 91.
    Madland TM, Apalset EM, Johannesen AE, Rossebö B, Brun JG (2005) Prevalence, disesae manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 32:1918–1922PubMedGoogle Scholar
  92. 92.
    Alamanos Y, Papadopoulos NK, Voulgari PV, Siozos C, Psychos DN, Tympanidou M et al (2003) Epidemiology of psoriatic arthritis in Northwest Greece, 1982–2001. J Rheumatol 30:2641–2644PubMedGoogle Scholar
  93. 93.
    Shbeeb M, Uramoto KM, Gibson LE, O’Fallon WM, Gabriel SE (2000) The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol 27:1247–1250PubMedGoogle Scholar
  94. 94.
    Nakae K, Masaki F, Hashimoto T (1993) Recent epdemiological features of Behçet’s disease in Japan. In: Godea P, Wechsler B (eds) Behçet’s disease. Proceedings of the 6th ınternational conference on Behçet’s disease. Elsevier, Amsterdam, pp 145–151Google Scholar
  95. 95.
    Hochberg MC (2001) Gout. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 230–246Google Scholar
  96. 96.
    Darmawan J, Valkenburg HA, Muirden KD, Wigley RD (1992) The epidemiology of gout and hyperuricemia in a rural population of Java. J Rheumatol 19:1595–1599PubMedGoogle Scholar
  97. 97.
    Nossent HC (2001) Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 28:539–546PubMedGoogle Scholar
  98. 98.
    Govoni M, Castellino G, Bosi S, Napoli N, Trotta F (2006) Incidence and prevalence of systemic lupus erythematosus in a district of north Italy. Lupus 15:110–113PubMedCrossRefGoogle Scholar
  99. 99.
    Johnson AE, Gordon C, Palmer RG, Bacon PA (1995) The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 38:551–558PubMedCrossRefGoogle Scholar
  100. 100.
    Hopkinson ND, Doherty M, Powell RJ (1994) Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 53:675–680PubMedCrossRefGoogle Scholar
  101. 101.
    Nightingale Al, Farmer RD, de Vries CS (2007) Systemic lupus erythematosus prevalence in the UK: methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease. Pharmacoepidemiol Drug Saf 16:144–151PubMedCrossRefGoogle Scholar
  102. 102.
    Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J (1991) High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 50:490–492PubMedCrossRefGoogle Scholar
  103. 103.
    Danchenko N, Saita JA, Anthony MS (2006) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15:308–318PubMedCrossRefGoogle Scholar
  104. 104.
    Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, Al-Saleh SS, Bahabri SA, Mousa MM et al (2002) Prevalence of systemic erythematosus in central Saudi Arabia. Saudi Med J 23:87–89PubMedGoogle Scholar
  105. 105.
    Naleway AL, Davis ME, Greenlee RT, Wilson DA, McCarty DJ (2005) Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 14:862–866PubMedCrossRefGoogle Scholar
  106. 106.
    Bernatsky S, Joseph L, Pineau CA (2007) A population-based assessment of systemic lupus erythematosus incidence and prevalence-results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford) 46:1814–1818CrossRefGoogle Scholar
  107. 107.
    Jimenez S, Cervera R, Font J, Ingelmo M (2003) The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol 25:3–12PubMedCrossRefGoogle Scholar
  108. 108.
    Ward MM (2004) Prevalence of physician-diagnosed systemic lupus eryhematosus in the United Stades: results from the third national health and nutrition examination survey. J Womens Health (Larchmt) 13:713–718 (abstract)CrossRefGoogle Scholar
  109. 109.
    Hochberg MC, Perlmutter DL, Medsger TA, Steen V, Weisman MH, White B et al (1995) Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 4:454–456PubMedCrossRefGoogle Scholar
  110. 110.
    Silman AJ (2001) Scleroderma. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 141–162Google Scholar
  111. 111.
    Mayes MD (1997) Epidemiology of systemic sclerosis and related diseases. Curr Opin Rheumatol 9:557–561PubMedCrossRefGoogle Scholar
  112. 112.
    Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI et al (1989) Prevalence of scleroderma spectrum disorders the general population of south Carolina. Arhritis Rheum 32:998–1006CrossRefGoogle Scholar
  113. 113.
    Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ et al (2003) Prevalence, incidence, survival, and disease charecteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246–2255PubMedCrossRefGoogle Scholar
  114. 114.
    Voulgari PV, Alamanos Y, Papazisi D, Christou K, Papanikolaou C, Drosos AA (2000) Prevalence of Raynaud’s phenomenon in a healthy Greek population. Ann Rheum Dis 59:206–210PubMedCrossRefGoogle Scholar
  115. 115.
    Román Ivorra JA, Gonzálvez Perales JL, Fernández Carballido C, Graña J, Torres MJ (2001) Prevalence of Raynaud’s phenomenon practice in the east of Spain. Clin Rheumatol 20:88–90PubMedCrossRefGoogle Scholar
  116. 116.
    Palmer KT, Griffin MJ, Sydall H, Pannett B, Cooper C, Coggon D (2000) Prevalence of Raynaud’s phenomenon in Great Britain and its relation to hand transmitted vibration: a national postal survey. Occup Environ Med 57:448–452 (abstract)PubMedCrossRefGoogle Scholar
  117. 117.
    De Angelis R, Salaffi F, Grassi W (2006) Raynaud’s phenomenon: prevalence in Italian population sample. Clin Rheumatol 25:506–510PubMedCrossRefGoogle Scholar
  118. 118.
    Weinrich MC, Maricq HR, Keil JE, McGregor AR, Diat F (1990) Prevalence of Rayanud’s phenomenon in the adult population of South Carolina. J Clin Epidemiol 43:1343–1349PubMedCrossRefGoogle Scholar
  119. 119.
    Gelber AC, Wigley FM, Stallings RY, Bone LR, Barker AV, Baylor I et al (1999) Symptoms of Raynaud’s phenomenon in an iner-city African-American community: prevalence and self reported cardiovascular comorbidity. J Clin Epidemiol 52:441–446PubMedCrossRefGoogle Scholar
  120. 120.
    Onbasi K, Sahin I, Onbasi O, Ustün Y, Koca D (2005) Raynaud’s phenomenon a healthy Turkish population. Clin Rheumatol 24:365–369PubMedCrossRefGoogle Scholar
  121. 121.
    Pirim I, Atasoy M, Ikbal M, Erdem T, Aliagaoglu C (2004) HLA class I and class II genotyping in patients with Behcet’s disease: a regional study of eastern part of Turkey. Tissue Antigens 64:293–297PubMedCrossRefGoogle Scholar
  122. 122.
    Uyar FA, Dorak MT, Saruhan-Direskeneli G (2004) Human leuıkocyte antigen-A, -B and -C alleles and human leukocyte antigen haplotypes in Turkey: relationship to other populations. Tissue Antigens 64:180–187PubMedCrossRefGoogle Scholar
  123. 123.
    Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S (1997) Epidemiological and clinical features of Behçet’s disease in Korea. Yonsei Med J 38:428–436PubMedGoogle Scholar
  124. 124.
    Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O et al (2008) Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 35:305–309PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Necati Çakır
    • 1
    • 9
  • Ömer Nuri Pamuk
    • 1
  • Emine Derviş
    • 2
  • Neşe İmeryüz
    • 3
  • Haşim Uslu
    • 4
  • Ömer Benian
    • 5
  • Edip Elelçi
    • 6
  • Genco Erdem
    • 6
  • Fatma Oğuz Sarvan
    • 7
  • Mustafa Şenocak
    • 8
  1. 1.Division of Rheumatology, Medical FacultyTrakya UniversityEdirneTurkey
  2. 2.Department of DermatologyHaseki State HospitalIstanbulTurkey
  3. 3.Division of Gastroenterology, Medical FacultyMarmara UniversityIstanbulTurkey
  4. 4.Division of OphthalmologyMedipol HospitalIstanbulTurkey
  5. 5.Division of Ophthalmology, Medical Faculty, EdirneTrakya UniversityEdrineTurkey
  6. 6.Medical FacultyTrakya UniversityIstanbulTurkey
  7. 7.Division of Genetics, İstanbul Medical Facultyİstanbul UniversityIstanbulTurkey
  8. 8.Department of Biostatistics, Cerrahpaşa Medical Facultyİstanbul UniversityIstanbulTurkey
  9. 9.Altunizade, Okul SokakIstanbulTurkey

Personalised recommendations